APA ציטוט

Cohen, M. H., Shen, Y. L., Keegan, P., & Pazdur, R. (2012). FDA Drug Approval Summary: Bevacizumab (Avastin®) as Treatment of Recurrent Glioblastoma Multiforme. AlphaMed Press.

Citação norma Chicago

Cohen, Martin H., Yuan Li Shen, Patricia Keegan, and Richard Pazdur. FDA Drug Approval Summary: Bevacizumab (Avastin®) As Treatment of Recurrent Glioblastoma Multiforme. AlphaMed Press, 2012.

ציטוט MLA

Cohen, Martin H., Yuan Li Shen, Patricia Keegan, and Richard Pazdur. FDA Drug Approval Summary: Bevacizumab (Avastin®) As Treatment of Recurrent Glioblastoma Multiforme. AlphaMed Press, 2012.